HOYA (7741) AI Stock Analysis

• Market Cap: $9.39T
• Dividend Yield: 1.01%
• Average Volume (3M): 1.07M
• Price to Earnings (P/E): 21.9
• Beta (1Y): 0.83
• Revenue Growth: 8.83%
• EPS Growth: 8.63%
• Country: JP
• Employees: 35,702
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): N/A
• Shares Outstanding: 338,414,300
• 10 Day Avg. Volume: 1,057,600
• 30 Day Avg. Volume: 1,072,613
• PEG Ratio: 2.25
• Price to Book (P/B): 5.99
• Price to Sales (P/S): 6.73
• P/FCF Ratio: 31.16
• Enterprise Value/Market Cap: 0.96
• Enterprise Value/Revenue: 9.88
• Enterprise Value/Gross Profit: 12.38
• Enterprise Value/Ebitda: 24.22
• 1Y Price Target: $30,130.72
• Price Target Upside: 8.38% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 10
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 80 Outperform
• Price Target: ¥32,715.00 ▲(17.68% Upside)
• Action: Reiterated Date: 02/01/26
• Date: Action: Reiterated 02/01/26

The score is primarily driven by strong financial performance (high profitability, very low leverage, and solid cash generation) and supportive technical momentum (price above key moving averages with positive MACD). These strengths are tempered by a relatively expensive valuation (high P/E and low dividend yield).

Positive Factors

Conservative balance sheet

Extremely low leverage limits financial risk and preserves strategic optionality. With debt-to-equity near 0.04, HOYA can fund M&A, capex, or shareholder returns without stressing credit metrics, making the business more resilient across multi-quarter economic cycles.

Strong cash generation

Operating cash exceeding net income and positive, growing free cash flow indicate durable cash conversion. This supports reinvestment in R&D/capex, consistent shareholder returns, and enables flexibility during downturns without needing external financing over the medium term.

High profitability and margins

Sustainably high gross and operating margins reflect structural pricing power and efficient operations across vision, medical, and precision segments. Strong margins underpin durable earnings power and support ROE (~0.21 TTM), cushioning slower top-line periods and enabling funding for growth initiatives.

Negative Factors

Slowing revenue growth

A more mature growth profile reduces organic upside and places greater reliance on margin expansion, acquisitions, or buybacks to lift EPS. If top-line momentum remains modest over several quarters, returns could increasingly hinge on efficiency gains rather than volume or market share gains.

Free cash flow below net income

FCF materially below net income suggests working capital swings or reinvestment absorbing cash. Over a multi-quarter horizon this can limit incremental distributions or strategic investments unless FCF conversion improves, constraining financial flexibility despite strong accounting profits.

Cyclical exposure in technology segment

Precision components revenue tied to electronics and semiconductor cycles introduces structural volatility. Downturns in end markets can depress orders and utilization for several quarters, complicating capacity planning and undermining revenue stability despite diversified end-markets.

HOYA Business Overview & Revenue Model

Company Description

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

How the Company Makes Money

HOYA generates revenue through multiple key streams. The Healthcare segment contributes significantly by selling intraocular lenses and surgical instruments for cataract surgery, as well as a variety of eyeglass lenses and contact lenses. Revenue in this sector is bolstered by ongoing demand for vision correction products and an aging population. The Electronics segment generates income by supplying photomasks and other critical materials used in semiconductor fabrication, catering to major tech companies in the electronics industry. Strategic partnerships with leading semiconductor manufacturers and healthcare providers enhance HOYA's market presence and revenue opportunities. Additionally, the company invests in research and development to innovate and expand its product offerings, further driving growth and profitability.

HOYA Financial Statement Overview

Summary

High-quality fundamentals supported by strong profitability, a conservatively leveraged balance sheet (very low debt-to-equity), and solid operating/free cash flow. The key constraint is slower recent revenue growth, which may limit incremental earnings upside.

Income Statement

HOYA shows strong profitability with very high gross and operating margins in the latest TTM (Trailing-Twelve-Months), supporting resilient earnings power. Revenue growth is positive but modest in TTM versus stronger growth in earlier years, suggesting a more mature growth profile. Net margins remain healthy, but the pace of top-line expansion is the key constraint on a higher score.

Balance Sheet

The balance sheet is conservatively positioned with very low leverage (debt-to-equity ~0.04 in TTM (Trailing-Twelve-Months)) and a large equity base, limiting financial risk. Returns on equity are consistently strong (~0.21 in TTM (Trailing-Twelve-Months)), indicating effective capital use. The main weakness is not leverage-related, but rather that future returns will depend more on sustaining growth than on balance-sheet optimization.

Cash Flow

Cash generation is solid: operating cash flow exceeds net income in TTM (Trailing-Twelve-Months), indicating good earnings quality and cash conversion. Free cash flow is meaningfully positive and growing in TTM, supporting reinvestment and shareholder returns. A moderate drawback is that free cash flow is below net income (free cash flow to net income ~0.78 in TTM (Trailing-Twelve-Months)), implying working capital movements or reinvestment needs are absorbing part of cash generation.

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	916.38B	866.03B	762.61B	723.58B	661.47B	547.92B
Gross Profit	731.05B	693.58B	606.30B	567.05B	511.05B	424.21B
EBITDA	373.64B	309.48B	284.45B	266.20B	254.48B	196.57B
Net Income	250.40B	202.10B	181.38B	168.64B	164.51B	125.45B
Balance Sheet
Total Assets	1.31T	1.23T	1.20T	1.03T	992.84B	853.29B
Cash, Cash Equivalents and Short-Term Investments	580.58B	533.97B	525.16B	405.89B	419.40B	334.90B
Total Debt	41.44B	37.28B	29.24B	24.58B	21.60B	20.75B
Total Liabilities	264.22B	262.65B	241.36B	213.72B	203.78B	180.88B
Stockholders Equity	1.03T	974.02B	967.76B	818.32B	803.85B	688.00B
Cash Flow
Free Cash Flow	197.01B	187.19B	181.73B	168.36B	161.18B	120.57B
Operating Cash Flow	251.61B	235.11B	222.80B	201.83B	190.06B	151.81B
Investing Cash Flow	-7.71B	-35.82B	-35.81B	-39.93B	-29.13B	-29.79B
Financing Cash Flow	-247.38B	-187.72B	-110.89B	-202.16B	-106.89B	-115.67B

HOYA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 27800.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7741, the sentiment is Positive. The current price of 27800 is below the 20-day moving average (MA) of 27989.00, above the 50-day MA of 26948.80, and above the 200-day MA of 22318.75, indicating a neutral trend. The MACD of 192.52 indicates Positive momentum. The RSI at 51.89 is Neutral, neither overbought nor oversold. The STOCH value of 70.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7741.

HOYA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7741	80 Outperform	$9.39T	21.89	25.14%	1.01%	8.83%	8.63%
7780	74 Outperform	¥128.58B	9.26	7.81%	1.78%	3.17%	7.07%
7747	68 Neutral	¥836.83B	24.33	11.64%	0.82%	13.53%	-7.39%
4543	67 Neutral	¥3.01T	25.64	8.98%	1.22%	7.68%	10.08%
3046	65 Neutral	¥122.77B	23.93	27.95%	1.97%	17.13%	78.33%
7733	60 Neutral	¥1.51T	38.56	11.34%	1.01%	0.42%	34.76%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

HOYA Corporate Events

Hoya Corrects Notice on Intervention in Shareholder Derivative Suit

Hoya Corporation has issued a corrective notice regarding its previously announced intervention in a shareholder derivative lawsuit involving seven current and former directors and executives. The company clarified that its decision to support the defendants in the litigation was announced without reference to a same-day board meeting, removing wording that could have implied a specific procedural step.

The change is minor but underscores management’s sensitivity to the legal and governance framing of its involvement in the case. By tightening the description of how the intervention decision was made, Hoya appears focused on reducing potential ambiguity for shareholders and other stakeholders as the lawsuit proceeds.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen33513.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

Hoya Steps Into Shareholder Lawsuit to Support Current and Former Directors

Hoya Corporation has decided to intervene in a shareholder derivative lawsuit to support seven current and former directors, including its current president and CEO, after a board review concluded they bear no liability for alleged breaches under Japan’s Companies Act. The company maintains that the shareholder’s claims lack legal basis and says it will actively counter the assertions in court, while committing to provide further disclosures if new material developments arise.

The decision signals Hoya’s strong institutional backing for its leadership and former board members, aiming to protect management credibility and governance reputation amid the litigation. Investors and other stakeholders will be watching closely to assess any potential impact on corporate governance perceptions and legal risk, even as Hoya asserts there are no grounds for restitution or neglect-of-duty claims.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen33513.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

Hoya Reports Progress on ¥100 Billion Share Buyback Program

Hoya Corporation has disclosed the latest progress of its ongoing share buyback program authorized by its board on January 30, 2026, under which it is allowed to repurchase up to 5 million shares for a maximum of ¥100 billion through mid-July. Between February 2 and February 28, the company bought back 1,303,200 shares of common stock via market purchases on the Tokyo Stock Exchange for approximately ¥35.97 billion, signaling continued capital return to shareholders and potential support for its share price and capital efficiency metrics.

The accumulated repurchases to the end of February fully match the latest monthly execution figures, indicating that just over a quarter of the authorized monetary amount has been deployed so far while significant capacity remains for further buybacks. This staged execution suggests Hoya is pacing its purchases over the authorized period, which may give the company flexibility to respond to market conditions and underscores its ongoing focus on shareholder returns alongside its broader strategic and operational priorities.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen33513.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Faces Shareholder Derivative Suit Over 2016 Share Buyback

HOYA has disclosed that it was notified of a shareholder derivative lawsuit filed in the Tokyo District Court against seven current and former directors and executive officers. The suit, brought by an individual shareholder, seeks ¥23,624 million in damages related to alleged illegal treasury stock acquisitions conducted in 2016 that purportedly exceeded the distributable amount under Japan’s Companies Act.

The company said it has already issued the legally required electronic public notice regarding the case and emphasized that the claim targets individuals rather than the corporate entity itself. HOYA currently believes the lawsuit will not affect its business performance, but has pledged to make prompt disclosures if any material developments or impacts requiring announcement arise.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen31500.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Delivers Strong Q3 Earnings and Lifts Full-Year Profit Outlook

HOYA reported a strong performance for the three months ended December 31, 2025, with revenue rising 10.8% year-on-year to ¥244.7 billion and profit before tax surging 69.9% to ¥110.8 billion, lifting the profit margin to 45.3%. Quarterly profit attributable to owners of the company jumped 81.4% to ¥91.6 billion, driving basic earnings per share up to ¥270.54, while total assets and equity both increased and the equity ratio edged up to 78.7%, underscoring a solid financial position. Operating cash flow improved to ¥64.3 billion and free cash flow expanded to ¥59.5 billion despite higher capital expenditure and R&D spending, indicating robust cash generation alongside continued investment. Reflecting this momentum, HOYA raised its full-year outlook for the year ending March 31, 2026, projecting revenue of ¥940 billion and a 25%-plus increase in profit attributable to owners, signaling confidence in sustained earnings growth and reinforcing its competitive standing for investors and other stakeholders.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Highlights Assumptions and Risks Underpinning FY25 Q3 Outlook

In its FY25 third-quarter earnings presentation dated January 30, 2026, HOYA Corporation provided commentary that included forward-looking statements regarding its future plans and performance. These statements, based on management’s assumptions about macroeconomic conditions, market trends, competition, production capacity, financial metrics, regulatory and clinical outcomes, and broader risk factors such as pandemics, underscore the inherent uncertainty around HOYA’s outlook and highlight the range of external variables that could influence its operations and results.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Launches ¥100 Billion Share Buyback Targeting 1.48% of Outstanding Stock

HOYA CORPORATION’s board has approved a share repurchase program aimed at enhancing shareholder returns, improving capital efficiency and maintaining a flexible capital policy. The company will buy back up to 5 million shares, representing about 1.48% of its outstanding shares (excluding treasury stock), for a maximum total of 100 billion yen through market purchases on the Tokyo Stock Exchange between February 2 and July 17, 2026, with the repurchased shares slated for cancellation, a move that is expected to reduce share count and potentially support earnings per share and shareholder value.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA to Cancel 4.7 Million Treasury Shares to Boost Capital Efficiency

HOYA CORPORATION’s Board of Directors has approved the cancellation of 4,708,300 shares of its common stock, equivalent to 1.37% of shares outstanding, as part of a strategy to improve capital efficiency and enhance returns to shareholders by reducing the total number of shares in circulation. Following the cancellation, scheduled for January 9, 2026, the company will have 338,414,320 issued and outstanding shares, a move that is expected to support shareholder value by potentially increasing earnings per share and reinforcing HOYA’s shareholder-friendly capital allocation policy.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26561.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.